Boehringer's Mirapex Patent Declared Invalid
In a blow to German pharmaceutical company Boehringer Ingelheim International GmbH, a federal judge has ruled that a patent covering the company's restless leg syndrome treatment Mirapex is invalid due to...To view the full article, register now.
Already a subscriber? Click here to view full article